Clinical Trial: Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
Study Status: Completed
Recruit Status: RECRUITING
Condition: Melanoma (Skin)
Study Type: INTERVENTIONAL
Official Title: Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases
Brief Summary:
To learn if giving nivolumab in combination with relatlimab can help to control melanoma that has spread to the brain (melanoma with brain metastases).The safety and side effects of the study drug combination will also be studied.
Read more